Loading data
ACRENYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 54.83 m USD | 69.65 m USD | 92.93 m USD | 106.85 m USD | 102.07 m USD |
| Profit before tax | -617 k USD | -35.01 m USD | -38.91 m USD | 30.26 m USD | 61.18 m USD |
| Income tax expense | 285 k USD | -18 k USD | -39 k USD | 472 k USD | 722 k USD |
| Net income (reported basis) | -902 USD | -34.99 k USD | -38.87 k USD | 29.79 k USD | 60.46 k USD |
| Net income attributable to common shareholders | -902 k USD | -34.99 m USD | -38.87 m USD | 29.79 m USD | 60.46 m USD |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.